Fluocinonide-e Cream Generic Name & Formulations
Fluocinonide 0.05%; emollient base.
Fluocinonide-e Cream Indications
Fluocinonide-e Cream Dosage and Administration
Adults and Children
Apply thin film 2–4 times daily.
Fluocinonide-e Cream Contraindications
Do not use superpotent forms on face, groin, or axillae. Exclude viral disease (eg, chickenpox, measles).
Fluocinonide-e Cream Boxed Warnings
Fluocinonide-e Cream Warnings/Precautions
Treat infection if present; discontinue if infection persists or worsens. Do not use near eyes, or on diaper dermatitis or pre-existing skin atrophy. Do not use fluorinated steroids longer than 1 week on the face. Avoid abrupt cessation in chronic use. Systemic absorption increased by broken or inflamed skin, prolonged use, application to large surface area, or use of occlusive dressings. Occlude only if necessary; do not occlude higher potency products. Monitor adrenal function in children if a high potency product or occlusion is used, and in adults if more than 50g weekly of a high potency product is used. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, glucosuria, or irritation occurs. Use lowest effective dose and potency (esp. in children). Use caution if applying to face or body folds. Do not use continuously or for prophylaxis. Foams are flammable. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Fluocinonide-e Cream Pharmacokinetics
Fluocinonide-e Cream Interactions
Fluocinonide-e Cream Adverse Reactions
Burning, stinging, pruritus, erythema, skin atrophy, striae, miliaria, secondary infections, hypopigmentation, folliculitis, hypertrichosis, acneiform eruptions, dermal cracking and fissuring, telangiectasia, contact dermatitis, other local effects, immunosuppression, masks infections, HPA axis suppression (esp. in children).
Fluocinonide-e Cream Clinical Trials
Fluocinonide-e Cream Note
Formerly known under the brand name Lidex, Lidex-E.
Fluocinonide-e Cream Patient Counseling